Skip to content

K-Stock Briefing

https://kstockbriefing.com

  • About Us
  • Weekly News
  • IR Room
  • RESEARCH
    • Semiconductors
  • Disclosures
    • Semiconductors
    • Energy
    • Bio & Healthcare
    • Defense
    • Shipbuilding
    • Automotive
  • Toggle search form
  • [Disclosure] Hyundai Motor (005380) – Reference Price for Interim (Quarterly) Ex-Dividend (Hyundai Motor Preferred) / 2026-05-27 Disclosures
  • [Disclosure] Hana Micron (067310) – Setting of Closure Period of Shareholders’ Register or Record Date / 2025-12-16 Semiconductors
  • [Disclosure] Hanwha Ocean (042660) – Decision on Loan to Related Party / 2024-11-21 Disclosures
  • [Research] Samsung Electro-Mechanics (009150) – IBK Securities | AI-Driven Off-Season Resilience · Non-IT MLCC Expansion · Target Price Upgrade / 2025-10-30 RESEARCH
  • [Disclosure] Jusung Engineering (036930) – Results of General Shareholders’ Meeting / 2026-03-26 Semiconductors
  • [Disclosure] Samsung Biologics (207940) – Consolidated Financial Results (Preliminary) / 2026-07-23 Disclosures
  • [Disclosure] Jeju Semiconductor(080220) – Results of Extraordinary General Meeting of Shareholders / 2026-07-30 Disclosures
  • [Disclosure] Hanmi Semiconductor (042700) – Investor Relations (IR) Presentation / 2025-07-03 Semiconductors

[Disclosure] Samsung Electronics (005930) – (Correction) Provisional Consolidated Financial Results (Fair Disclosure) / 2025-10-30

Posted on October 30, 2025July 29, 2026 By K-STOCK Editor

Fact Source: Financial Supervisory Service DART

💡 3-Second Summary

Samsung Electronics filed a correction to its preliminary Q3 2025 earnings reported on Oct 14, 2025, revising Q3 revenue upward to KRW 86.06T (from 86.00T) and operating profit to KRW 12.17T (from 12.10T).

📊 [Key Disclosure Details & Financial Summary]

  • Disclosure Category: Correction of Provisional Consolidated Operating Results (K-IFRS)
  • Original Filing Date: October 14, 2025
  • Reason for Correction: Revisions to Q3 2025 provisional figures and note disclosures
  • Key Corrected Items (Unit: Trillion KRW, %):
    • Q3 2025 Revenue (Quarterly): KRW 86.00T ➔ KRW 86.06T (QoQ: 15.33% ➔ 15.42%, YoY: 8.72% ➔ 8.80%)
    • Q3 2025 Revenue (Cumulative): KRW 239.71T ➔ KRW 239.77T (YoY: 6.50% ➔ 6.52%)
    • Q3 2025 Operating Profit (Quarterly): KRW 12.10T ➔ KRW 12.17T (QoQ: 158.55% ➔ 160.18%, YoY: 31.81% ➔ 32.48%)
    • Q3 2025 Operating Profit (Cumulative): KRW 23.46T ➔ KRW 23.53T (YoY: -10.56% ➔ -10.31%)
  • Note Revision:
    • Deleted the clause: “The company plans to re-disclose earnings upon Board of Directors approval for the Q3 2025 financial results.”
  • Other Details: Provisional figures provided prior to the completion of the external audit, subject to potential adjustments.

📝 Editor’s Comment (Key Follow-up Checkpoint)

📌 Reflection of Corrected Provisional Results in Periodic Reports

This disclosure contains upward corrections to the provisional revenue and operating profit figures initially released on October 14, 2025, along with minor updates to notes. Verifying whether these corrected provisional figures are finalized without further adjustments through the auditing process in upcoming periodic business reports (Quarterly Business Reports) and Audit Reports is important for confirming the ultimate accuracy of the financial performance data. Finalized details can be verified in future periodic reports and Audit Reports.

📢 Disclaimer & Source Information

Source: This content was newly structured and generated based on official submission data from the Financial Supervisory Service’s Data Analysis, Retrieval and Transfer System (DART).

Investment Risk Warning: This content is provided solely for informational and linguistic reference purposes. Under no circumstances does it constitute financial advice or a recommendation to buy or sell any specific stock. All investment decisions and financial liabilities rest entirely with the individual investor.

Contact: For compliance inquiries or copyright concerns, please contact ksb220805@gmail.com.

Search by
Company Name or Stock Ticker.
Semiconductors, Disclosures

Post navigation

Previous Post: [Disclosure] Samsung Electronics (005930) – Provisional Consolidated Financial Results (Fair Disclosure) / 2025-10-30
Next Post: [Disclosure] Samsung Electronics (005930) – Other Management Matters (Voluntary Disclosure) / 2025-10-30

Related Posts

  • [Disclosure] Celltrion (068270) – Expiration of Part 1 Approval for Phase 3 Clinical Trial Plan of CT-P13 SC (Remsima Subcutaneous) in Europe Due to Development Strategy Change (Pediatric Ulcerative Colitis) / 2026-06-18 Bio & Healthcare
  • [Disclosure] Celltrion (068270) – Decision on Acquisition of Shares and Equity Securities of Other Corporation (Correction) / 2025-12-11 Disclosures
  • [Disclosure] Hanwha Systems (272210) – Major Management Matters Related to Investment Decisions / 2026-02-20 Disclosures
  • [Disclosure] HPSP (403870) – Change of Market Segment Classification / 2025-04-30 Semiconductors
  • [Disclosure] Celltrion (068270) – Approval of Supplemental sBLA for Interchangeability Designation of Yuflyma (CT-P17, Humira Biosimilar) in the U.S. / 2025-04-14 Disclosures
  • [Disclosure] HPSP (403870) – Decision on Closure of Register of Shareholders (Record Date) for Cash/In-Kind Dividend / 2024-11-06 Semiconductors
  • [Disclosure] Hyundai Motor (005380) – Submission of Audit Report / 2024-03-06 Disclosures
  • [Disclosure] Samsung Electronics (005930) – Other Management Matters (Voluntary Disclosure) / 2026-02-13 Semiconductors
  • [Disclosure] KEPCO (015760 / KEP) – Other Corporate Matters (Voluntary Disclosure) / 2026-03-30 Disclosures
  • [Research] SK hynix (000660 / SKHY) – SK Securities | Rising HBM Contribution · Price-Driven Cycle · Oversold Valuation / 2024-07-29 RESEARCH
  • [Disclosure] Hanwha Ocean (042660) – (Correction) Decision on Guarantees for Others / 2026-06-29 Disclosures
  • [Disclosure] Celltrion (068270) – Marketing Authorization Granted by South Korean MFDS for Eydenzelt (CT-P42, Eylea Biosimilar) / 2024-05-30 Disclosures
  • [Disclosure] Samsung Biologics (207940) – Provisional Operating Performance (Fair Disclosure) / 2025-10-28 Disclosures
  • [Disclosure] LEENO Industrial (058470) – Results of Annual General Meeting of Shareholders / 2026-03-26 Semiconductors

Copyright © 2026 K-Stock Briefing.

Powered by PressBook News Dark theme